Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?
about
Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease.Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores.Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders.Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base.Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population.Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?Serum Plant Sterols Associate with Gallstone Disease Independent of Weight Loss and Non-Alcoholic Fatty Liver Disease.Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic Steatosis.Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
P2860
Q33633689-C530A0CF-B0B2-4942-A896-02DC398037DAQ33780136-43E85472-7107-421D-80D1-BEFBC80A2B64Q34172798-EEC42510-9CA7-4EC4-9D87-1E642908AC9EQ36116709-32C0734F-60B9-47EC-90C4-13C817650AA1Q37058972-2A1E256D-E239-41E3-B9AD-BFC10E4641BBQ37378928-14A26221-1E19-4FD0-B7B4-A9311C562370Q38597198-1A59FA10-63F6-4A92-9218-0DB811A359C8Q42365416-F6223053-1EEE-4F1A-A13B-10C142B7C2D3Q42852539-73495535-E2AD-4630-BFEF-C74325312855Q43614017-3652997C-9C2C-4CDB-9993-1044566B3D2AQ43637362-1A4A444B-A2B4-42BD-BF57-C8664F789A83Q47260044-785F41A8-6C81-4040-922D-8AE6649577A8Q50154698-F466BAB3-BAFB-467B-984D-4F88F0DD1E58Q50167978-E01CC57A-C55A-4A55-BA09-8BD623DCBEAFQ50177399-F840D3D1-B1A7-4A55-BBC7-4E4F8B656E7E
P2860
Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Routine liver biopsy to screen ...... tone disease: is it justified?
@en
Routine liver biopsy to screen for nonalcoholic fatty liver disease
@nl
type
label
Routine liver biopsy to screen ...... tone disease: is it justified?
@en
Routine liver biopsy to screen for nonalcoholic fatty liver disease
@nl
prefLabel
Routine liver biopsy to screen ...... tone disease: is it justified?
@en
Routine liver biopsy to screen for nonalcoholic fatty liver disease
@nl
P2093
P1476
Routine liver biopsy to screen ...... tone disease: is it justified?
@en
P2093
Alfonso G Pérez-Morales
Federico B Roesch-Dietlen
Silvia Cid-Juarez
Silvia Martinez
P2860
P2888
P304
2097-102; discussion 2102
P356
10.1007/S11605-008-0704-7
P577
2008-09-30T00:00:00Z